Prenatal Screening 

Congenital malformations can complicate approximately 3–5% of pregnancies. Many congenital malformations are associated with aneuploidy, structural chromosomal rearrangements (large or submicroscopic), and copy number variants (CNVs). While some of these mutations can be diagnosed with G-band karyotyping, QF-PCR, or microarray analysis, interpreting monogenic disorders prenatally using next-generation sequencing (NGS) techniques allows a better and more accurate assessment.

Achieving a genetic diagnosis in fetal life may improve clinical care by informing individualized genetic counseling for current and future pregnancies, allowing discussion regarding prognosis and treatment with the appropriate pediatric specialists. It may support parents in decision-making regarding the termination of pregnancy.

Golden Helix and its VarSeq suite of products has vast capabilities that can be leveraged in the Non-invasive Prenatal Screening space. We enable precise and vast analytics capabilities, a scalable platform that allows labs to ramp up their testing capabilities and a simple business model.

VarSeq is an intuitive, integrated software solution for tertiary analysis. With VarSeq you can automate your workflows and analyze variants for gene panels, exomes, and whole genomes. Understanding genomic data has never been easier thanks to our software.

VarSeq helps clinical testing laboratories complete the time-critical and patient-centric workflows for gene testing and rare disease diagnosis.

Comprehensive Workflows: The VarSeq clinical stack supports all of the steps necessary to provide clinical genetic tests from the raw VCF variants to the signed out clinical report. VarSeq's flexibility allows you to customize workflows to the individual gene panel or exome test.
Supported Genetics Tests Include: Diagnostic testing used to identify the presence or absence of causal genetic variations for specific disease , predictive and pre-symptomatic genetics tests designed to identify hereditary gene changes that can increase the lifetime risk of developing diseases, and Newborn Screening used to test babies soon after birth to identify highly penetrant variants for certain diseases known to cause problems with health and development.
Rare Disease Diagnosis: VarSeq includes first-class support for the more complex workflows associated with discovering the causal variants of rare disease. This includes using related samples in trios and quad analysis, algorithms that detect inheritance patterns of variants, ranking of rare patheogenic variants by their relevance to the phenotype terms provided by differential diagnositics and the integration of the public and premium annotations sources.

Get in Contact

If you are interested in starting a discussion about how Golden Helix software can assist in prenatal screening, please fill out the form below, and we will send you the details!

Recommended Learning Materials

We have a variety of supplemental learning materials that are an excellent resource for anyone interested in the industry or our software solutions. Here are some of our recommended materials for you to check out related to VarSeq!